Introduction
Cerebral amyloid angiopathy (CAA) is a common cerebral small vessel disease that involves the accumulation of amyloid -protein (A) primarily in small-and mediumsized arteries and arterioles of the meninges and cerebral cortex as well as along the capillaries of the cerebral microvasculature [1] [2] [3] [4] [5] [6] . CAA has been shown to be present, in varying degrees, in nearly 80% of elderly individuals 7, 8 . With the involvement of A, it is not surprising that CAA is a very common vascular comorbidity in patients with Alzheimer's disease (AD) 3, [7] [8] [9] . Even when controlling for confounders including AD, CAA is a significant contributor to vascular-mediated cognitive impairment and dementia (VCID) and is independently associated with worse cognition and dementia 7, 8, [10] [11] [12] [13] . In addition to the sporadic cases of CAA and the prominent CAA that is observed in AD, several monogenic, familial forms of CAA exist that result from mutations that reside within the A peptide sequence of APP gene including the Dutch E22Q and Iowa D23N variants [12] [13] [14] .
CAA can present as two prominent forms known as CAA type-1 and CAA type-2 6 . In CAA-type 2 the amyloid deposition is largely restricted within the vessel wall of the meningeal and cortical arterioles and generally does not promote perivascular neuroinflammation 5, 6, 15 . In contrast, CAA type-1 involves amyloid deposition along transitional cerebral microvessels and capillaries and is present in nearly half of AD cases 5, 6 . In contrast to larger vessel CAA type-2 where the amyloid is largely confined within the vessel wall, CAA type-1 results in penetrance of the fibrillar amyloid deposits into the surrounding brain parenchyma -so called "dyshorric amyloid" -a feature which promotes a strong perivascular neuroinflammatory response 5, 6, 16, 17 . In particular, cerebral microvascular amyloid deposition is often correlated with worse cognition and dementia in individuals afflicted with AD and sporadic/familial CAA disorders [18] [19] [20] [21] [22] .
Transgenic mice, which robustly over-express human APP in brain and develop cerebral A deposits, have been a significant advancement for the study of the pathogenic effects of brain A accumulation in vivo. Several well-established transgenic mouse lines have been developed that over-produce human A peptides in brain that develop age-dependent accumulation of parenchymal A deposits with varying degrees of CAA and associated vasculopathies [23] [24] [25] [26] . Specifically, transgenic mouse lines were developed that express human APP in brain harboring one or more of the familial CAA mutations 27, 28 . Importantly, these familial CAA transgenic mouse lines revealed the specific role of CAA in neuroinflammation and VCID [29] [30] [31] [32] . However, as with all mouse models, CAA transgenic mice possess some significant limitations to more fully recapitulate and study the equivalent human condition. In particular, consistent and robust microbleeds have been elusive in most CAA mouse models. Therefore, more appropriate animal models of small vessel CAA are necessary to progress our understanding of the pathogenesis, its contribution to structural changes in the brain and VCID.
Here we describe our efforts to generate and characterize a new transgenic rat model (rTg-DI) for small vessel CAA. We demonstrate that rTg-DI rats exhibit early-onset and progressive accumulation of cerebral microvascular fibrillar amyloid accompanied by behavioral deficits. Fibrils seeded from the vascular amyloid isolated from rTg-DI rats exhibit intense bands in Fourier transform infrared (FTIR) spectra characteristic of antiparallel -sheet similar to that previously observed for human cerebral vascular amyloid 33 . Moreover, in rTg-DI rats the cerebral microvascular A deposits cause capillary structural changes, promote prominent perivascular glial activation and produce consistent, robust microhemorrhages with small vessel occlusions that are readily detected by magnetic resonance imaging.
Materials and Methods
Generation of Transgenic Rats All work with animals followed National Institutes of Health guidelines and was approved by the University of Rhode Island, Yale University and Stony Brook University Institutional Animal Care and Use Committees. A pcDNA3 vector containing 2.1 kb of human APP (isoform 770) cDNA was used to introduce the mutations Swedish K670N/M671L, Dutch E693Q, and Iowa D694N using the QuikChange kit (Stratagene, La Jolla, CA). The APP770-SwDI cDNA was amplified by PCR using primers containing the NheI 5-linker and SacII 3-linker. The PCR product was digested and subcloned between exons II and IV of a Thy1.2 expression cassette using NheI and SacII restriction sites. The completed construct was entirely sequenced to confirm its integrity. The 9-kb transgene was liberated by NotI/PvuI digestion, purified, and microinjected into pronuclei of Sprague-Dawley single cell embryos. Founder rats were identified by Southern blot analysis of tail DNA. Transgenic offspring were determined by PCR analysis of tail DNA using the following primers specific for human APP:
5'-CCTGATTGATACCAAGGAAGGCATCCTG-3' and 5'-GTCATCATCGGCTTCTTCTTCTTCCACC-3' (generating a 500-bp product). All subsequent analyses were performed with heterozygous transgenic rats.
Immunoblot Quantitation of APP. Rat forebrain tissues were homogenized in 10 volumes of 50 mM Tris-HCl (pH 7.5) containing 150 mM NaCl, 1% SDS, 0.5% Nonidet P-40, 5 mM EDTA, and proteinase inhibitor mixture (Roche Applied Science, Indianapolis, IN). The tissue homogenates were clarified by centrifugation at 14,000 x g for 10 min.
Protein concentrations of the resulting supernatants were determined using the BCA protein assay Kit (Fisher Scientific, Houston, TX). The levels of APP in the forebrain tissue homogenates were determined by performing quantitative immunoblotting as described 27 . Samples were probed either with monoclonal antibody P2-1, which is specific for human APP 34 , or with monoclonal antibody 22C11 (Chemicon International, Inc., Temecula, CA), which detects both rat and human APP. Bands corresponding to APP were measured using a LICOR imaging system (Lincoln, NE).
Quantitation of A Peptides
Soluble pools of Aβ40 and Aβ42 were determined by performing specific ELISAs on carbonate extracted rat forebrain tissue and subsequently the insoluble Aβ40 and Aβ42 levels were determined by ELISA of guanidine lysates of the insoluble pellets resulting from the carbonate extracted rat brain tissue as described 35, 36 . In the sandwich ELISAs Aβ40 and Aβ42 were captured using their respective carboxyl-terminal specific antibodies mAb2G3 and mAb21F12 and biotinylated m3D6, specific for human Aβ, was used for detection 35 . Cerebral microvessels were isolated from rat forebrains as described 27, 37 . The levels of cerebral microvascular A40 and A42 levels were measured in guanidine lysates of the brain microvessels isolated from rTg-DI rats. Each rat brain or microvessel lysate was measured in triplicate and compared to linear standard curves generated with known concentrations of human Aβ using a Spectramax M2 plate reader (Molecular Devices, Sunnyvale, CA).
Isolation of cerebral capillary amyloid seeds. Brain capillaries were isolated from the cortices of twelve months old rTg-DI rats as described 27, 37 . The isolated microvessels were analyzed microscopically by staining with thioflavin S and immunolabeling with an antibody to collagen IV to confirm the isolation of amyloid-containing microvessels. The remaining microvessels were treated with 3 mg/ml collagenase at 37 o C overnight. The collagenase treated samples were centrifuged at 16,000 x g for 5 min and the resulting pellet was washed twice with TBS. The amyloid pellet was resuspended in TBS and again analyzed microscopically by staining with thioflavin S and immunolabeling with an antibody to collagen IV to confirm the isolation of vascular amyloid deposits and the absence of microvessels.
Seeding of fibrils from vascular amyloid. For the preparation of fibrils from isolated vascular amyloid, isolated vascular amyloid was sonicated for using a Fisher Scientific tip sonicator at 30% power in four 10 sec bursts. Monomeric (synthetic) A40-WT peptide was added to the seeds in 3 steps at 1 h intervals. The A40-WT peptide was synthesized using N-t-Boc chemistry on an ABI 430A solid-phase peptide synthesizer (ERI Amyloid Laboratory, Oxford, CT) and purified by high performance liquid chromatography (HPLC).
Based on analytical reverse phase HPLC, the peptide purity was greater than 98%. The mass of the purified peptide was measured using matrix-assisted laser desorption or electrospray ionization mass spectrometry and was consistent with the calculated mass for the peptide. The peptides were isotopically labeled with 1-13 C at Leu17, Ala21, Gly33
and Gly37 for FTIR measurements. Purified, lyophilized A peptides were aliquoted in hexafluoroisopropanol and freeze-dried for at least 4 days with a vacuum of 25 mTorr.
For preparing monomeric A, the peptide was dissolved in 50 mM NaOH at a concentration of 2.2 mM, then diluted in 10 mM phosphate buffer (pH 7.4) at low temperature (4 °C). The Aβ solutions were then filtered with a 0. was performed either using Amylo-Glo as described by the manufacturer (Biosensis Inc., Thebarton, South Australia) or using thioflavin S. The following antibodies were used for immunohistochemical analysis: mAb66.1 (1:250), which recognizes residues 1-5 of human A 38 ; mAb2B4 to detect A42 (1:1000) and rabbit polyclonal antibody to detect A40 (1:200; Biosource, Camarillo, CA) A42, respectively; rabbit polyclonal antibody to collagen type IV to visualize cerebral microvessels (1:100; ThermoFisher, Rockford, IL);
and rabbit polyclonal antibodies to GFAP (1:200; Dako, Santa Clara, CA) and Iba-1
(1:200; Fujifilm Wako Pure Chemical, Osaka, Japan) for detection of astrocytes and microglia, respectively. Prussian blue iron staining was performed to detect hemosiderin deposits reflecting signs of previous microhemorrhage 39, 40 . Von Kossa calcium staining was used to detect small vessel occlusion/calcifications in the brain 41 . In this case, tissue sections were counterstained with pararosanline.
Quantitative Analysis of Vascular Pathologies
The percent area amyloid coverage of cerebral microvessels, percent area iron staining and the numbers of occluded/calcified vessels in the frontotemporal cortex, thalamic, and hippocampal regions was determined in rats at each of the specified ages using stereological principles as described 42 .
Cerebral microvessel tortuosity in different brain regions was determined by immunolabeling the vessels in brain tissue sections, measuring both the traced actual vessel length and the direct straight line, end to end vessel length and dividing the actual length/direct length.
Novel Exploration Behavioral Task A novel exploration paradigm was included to measure perceptual slowing as represented in a slowed rate of stimulus encounters. This was a common deficit observed in the similar Tg-SwDI mouse model 31 . Typically, animals were placed in the open field apparatus to explore four novel and distinct objects for a 5-min trial period. Interaction with an object was scored by the AnyMaze tm software as entering into a predetermined zone surrounding the object.
Magnetic Resonance Imaging Analysis
All rats were deeply anesthetized with ketamine/xylazine (75 mg/kg / 10 mg/kg) i.p. followed by trans-cardial perfusion fixation.
First, vascular perfusion was conducted with 0.1% heparin/PBS (20cc/min for 5 min);
followed by 5% Magnevist in 10% buffered formalin solution (120 ml/rat at 20cc/min) using a Pharmacia LKB P-1 peristaltic pump. Following perfusion fixation of the 12 months old male rTg-DI and wild-type rats, the brains were removed from the skull with great care so as to not damage the brain parenchyma. The brain specimens were immersed in PBS for The MRIs were displayed as isotropic 3D volumes using Amira software (Version 6.2). 3D MRIs acquired with a TE of 7ms and 18ms were used for the matching process.
The process to match the MRIs to the corresponding histological brain slice involved several computational steps; and in all processing the histological brain slice served as the master template or 'reference' and the 3D MRI was manipulated to match it. First, 3-5 histological slices of interest were chosen which included thalamic iron staining-positive areas of micro-hemorrhages. Using the 'slice' feature in Amira, the MRI slice plane that best matched the histological slice -(based on anatomical landmarks such as the shape of the hippocampus, the corpus callosum, the fimbria and the shape of the ventral surface)
were defined. Using rigid matching (scaling in x-and y-directions) the MRI was matched to the histological slice. Finally, the histological slice was overlaid onto the matched 2D
MRI to determine the MRI signatures associated with the iron stain-positive areas.
Statistical Analysis Histological and biochemical data were analyzed by t-test at the 0.05 significance level. Behavioral testing data were analyzed by t-tests and the performance of each subject for each testing day was the average latency of the two trials.
Results

Low Level Expression of Human CAA Mutant APP in Brain Results in Progressive and Extensive Microvascular CAA
To target production of human chimeric Dutch/Iowa CAA mutant in neurons of rat brain we took a similar approach that was successfully used in the previous generation of our Tg-SwDI mouse line 27 . We used the neuronal-specific Thy1.2 expression cassette to drive expression human APP harboring the familial AD Swedish K670N/M671L mutations and the familial CAA Dutch E693Q and Iowa D694N mutations in neurons in the rat brain. The Swedish APP mutations were included solely to enhance -secretase processing and production of A peptides 43 . The familial CAA Dutch and Iowa mutations were included in the transgene to yield chimeric Dutch/Iowa CAA mutant A peptides in brain which exhibit markedly enhanced fibrillogenic and vascular pathogenic properties 44, 45 . The transgenic rats (rTg-DI) were generated by microinjection of the human APP770-SwDI construct into oocytes in a pure Sprague-Dawley background. The presence of the human APP transgene was confirmed in founder and subsequent offspring rats by PCR analysis. All rTg-DI rats used in the subsequent characterization experiments were heterozygous for the human APP transgene.
Two months old rTg-DI rats were evaluated for expression of the human APP transgene using the human APP-specific monoclonal antibody P2-1 34 .
Immunohistochemical analysis presented in Figure 1A -F shows that human APP expression was evident throughout the cortex, hippocampus and thalamus and was restricted to neurons. Immunoblot analysis using mAbP2-1 confirmed that human APP transgene expression was only observed in rTg-DI rats ( Figure 1G ). Subsequent quantitative immunoblot analysis using the total (rat + human) APP-specific mAb22C11
showed that human transgene APP expression was modest and only about 50% higher than the levels of endogenous rat APP seen in wild-type rats ( Figure 1H ).
The accumulation of human A peptides was measured in rTg-DI brains as they aged over 12 months. A sandwich ELISA format was used that detected only human A peptides 35, 36 . As the rTg-DI rats aged from 3-12 months there was a progressive increase in the amounts of soluble A40 in brain whereas the amounts of soluble A42 remained fairly constant over this time period ( Figure 1I ). The majority of soluble A peptides (>90%) at each age were the shorter A40 isoform. On the other hand, there was a progressive accumulation of both insoluble A40 and A42 as the rats aged ( Figure 1J ).
Again, the vast majority of accumulated insoluble A peptide was the shorter A40
isoform. These findings indicate that despite the low level of transgene human APP expression there is an early-onset and progressive accumulation of Dutch/Iowa CAA mutant A peptides in the brains of rTg-DI rats.
Early-Onset and Extensive Accumulation of Cerebral Microvascular Amyloid is
Associated with Behavioral Impairments and Exhibits a Characteristic Anti-Parallel Alignment.
Since insoluble levels of cerebral A markedly increase with age in rTg-DI rats the compartmental distribution of fibrillar amyloid was examined over time. Figure 2 shows that as early as 3 months of age there was notable accumulation of cerebral microvascular amyloid in the cortical, hippocampal and thalamic regions of the brain.
Further, as the rTg-DI rats aged to twelve months there was a dramatic increase in cerebral microvascular amyloid deposition with nearly 45% and 70% of capillaries covered in fibrillar amyloid in the thalamic and hippocampal regions, respectively ( Figure   2J ). Although the levels of capillary CAA were somewhat lower in the cortical areas still nearly 30% of vessel surface was covered. Importantly, Figure 2K shows that these early levels of capillary CAA in the rTg-DI rats were associated with the characteristic slowing in the manner of exploration of unique objects arrayed in an open field (i.e. the novel object exploration task) consistent with a form of perceptual slowing likely to result from cortico-thalamic and hippocampal dysfunction and present in CAA 7 .
Immunohistochemical analysis revealed that the vast majority of cerebral microvascular amyloid was comprised of A40 ( Figure 3A-C) . Further, ELISA analysis of isolated cerebral microvessels from rTg-DI rats confirmed that nearly 90% of the accumulated amyloid was composed of A40 peptide ( Figure 3D ,E). Fibrillar microvascular amyloid seeds were isolated from rTg-DI rats ( Figure 3F ) and FTIR spectroscopy revealed a strong -sheet secondary structural component characteristic of amyloid fibrils as indicated by the prominent spectral peak at ≈1632 cm -1 ( Figure 3G ).
Whereas wild-type A40 peptide slowly formed fibrils, the addition of the isolated microvascular amyloid seeds promoted rapid fibril assembly of wild-type A40 as assayed by thioflavin T fluorescence spectroscopy ( Figure 3H ). The rapid increase in fluorescence argues that the A monomers are using the structural template provided by the seeds as they associate with the growing fibrils. Recently, we found that fibrils seeded from cerebral vascular amyloid exhibited intense FTIR bands characteristic of antiparallel -strand structure 33 . Notably, the newly formed seeded wild-type A40 fibrils from rTg-DI microvascular amyloid exhibit a similar anti-parallel signature as reflected by the strong FTIR spectral band at ≈1607 cm -1 ( Figure 3I ).
Accumulation of Cerebral Microvascular Amyloid in rTg-DI Rats Promotes Capillary
Structural Changes and Perivascular Inflammation
The prominent accumulation of cerebral microvascular amyloid in rTg-DI rats caused pronounced structural changes to cerebral capillaries compared to similarly aged wild-type rats. These capillary changes included the appearance of numerous "string vessels", which are remnants of capillaries with no endothelial cells 46 , and prominent vessel fragmentation ( Figure 4B ). These structural changes were accompanied by a significant (p < 0.001) increase in the tortuosity of the cerebral capillaries in the affected brain regions further demonstrating the deleterious effects of vascular amyloid accumulation ( Figure 4C ). Additionally, there was a significant (p < 0.001) increase in capillary area in the thalamic region and an increased trend in the other brain regions which may reflect the increased tortuosity ( Figure 4D ).
We also observed that cerebral microvascular amyloid in rTg-DI rats, which engages the surrounding brain parenchyma, is associated with a strong neuroinflammatory response reflected by a robust increase of perivascular reactive astrocytes ( Figure 5B ) when compared to similarly aged wild-type rats devoid of microvascular amyloid ( Figure 5A ). Likewise, an elevated number of perivascular activated microglia are present in rTg-DI rats in areas with microvascular CAA ( Figure   5D ). It was also noted that the lower number of microglia present in the similarly aged wild-type rats were in the resting ramified surveillance mode with numerous extended processes ( Figure 5C ) whereas the elevated numbers of microglia in rTg-DI rats exhibited a bushy, activated morphology actively engaged with the fibrillar amyloid deposits on the cerebral capillaries ( Figure 5D ). These findings indicate that the presence of prominent cerebral microvascular amyloid in rTg-DI rats is accompanied by structural deterioration of brain capillaries and a robust increase in activated perivascular glial cells.
Robust Microhemorrhages and Small Vessel Occlusions are Detected by MRI in rTg-DI Rats
A prominent clinical feature of CAA in humans is the presence of cerebral microbleeds 1,2 . The presence of microbleeds was histochemically evaluated by Perl's staining for perivascular hemosiderin deposits in groups of progressively aged rTg-DI rats. Evidence of cerebral microbleeds was observed in the cortical and hippocampal regions of 12 months old rTg-DI rats ( Figures 6A and 6B, respectively) . However, microbleeds were particularly abundant in the thalamic region of the brain with various presentations of perivascular iron deposits including tightly-associated crescent shaped deposits ( Figure 6C ), complete circumferential involvement ( Figure 6D ), indications of multiple bleeds in several adjacent microvessels ( Figure 6E ) and more diffuse perivascular iron deposits ( Figure 6F ). Since it was often difficult to discriminate between individual and grouped microbleeds we measured the area of iron deposition in the different brain regions at 6 and 12 months. As shown in Figure 6G , signs of microbleeds in the cortex were not observed at 6 months and were low at 12 months. However, in the hippocampus small areas of microbleeds were detected at 6 months and this increased as the rTg-rats aged to 12 months. Most notably, in the thalamus there was clear evidence of microbleeds at 6 months which dramatically increased at 12 months of age with >1% of the total thalamic area covered with perivascular iron deposits. Although microbleeds are numerous in 12 months old rTg-DI rats large macrobleeds have not been observed at this age.
Small vessel occlusions and calcifications are other microvasculopathies observed in CAA patients 2, 47, 48 . Interestingly, in the thalamic region of prevalent microbleeds in rTg-DI rats we noted numerous occluded microvessels ( Figure 7A ). Calcium staining of adjacent brain tissue sections indicated calcifications in these small vessel occlusions surrounded by areas of fibrinoid necrosis ( Figure 7B ). These microvascular occlusions were bilateral and largely restricted to the ventral posterior lateral nucleus of the thalamic region ( Figure 7C ). The overall numbers of these thalamic small vessel occlusions were quantified in rTg-DI rats as they aged from 3 to 12 months of age. As shown in Figure 7D , the occlusions were extremely rare or absent at 3 months of age. However, at 6 and 12 months the numbers markedly increased to ≈40 and ≈115 small vessel occlusions, respectively in this thalamic region. At each age the majority of the vessel occlusions were in capillaries but occasionally larger microvessels were also occluded.
We next performed studies in rTg-DI rats to characterize the microhemorrhages in situ using in vitro MR microscopy. Figure 8 
Discussion
CAA is a common cerebral small vessel disease of the elderly and a prominent comorbidity of AD that promotes and exacerbates VCID, yet our understanding of the condition remains limited and despite the high prevalence there is no effective treatment.
Several transgenic mouse models, that develop varying levels of CAA, have been in use for more than a decade and have provided better insight into the pathogenesis of CAA [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] . However, their usefulness to further investigate CAA from the point of view of faithfully recapitulating the human condition is limited due to their biological evolutionary distance from humans and the small size of their brains which can be problematic for effective neuroimaging in vivo. Further, complicated cognitive testing to investigate VCID in the setting of evolving CAA can be unreliable due to temperamental variability in mice 49 .
Although naturally occurring models of CAA exist, most notably canines and non-human primates, the experimental use of these species for large cohort experimentation and testing is limited due to the cost and time needed for CAA to develop (decade or decades) 50 . Thus, there is a need for a better experimental model of CAA. The use of rats, specifically transgenic rats, to investigate the pathogenesis of human CNS disorders offers several distinct advantages over transgenic mice. First, rats are evolutionarily 4-5 million years closer to humans 51 . Thus, the genetics, physiology and brain morphology of rats are better suited to model human CAA. Second, the larger brain size and increased white-to-grey matter ratio of the rat enables structural neuroimaging studies with superior contrast-and signal-to-noise ratio compared to mice. Lastly, rats provide the opportunity for far more sophisticated cognitive testing compared to mice thereby bridging a gap in knowledge as to how CAA drives VCID 52 .
In the current study, we describe the generation and initial characterization of a novel transgenic rat model (rTg-DI) of microvascular type 1 CAA. The rTg-DI rats were designed from our earlier success in generating Tg-SwDI transgenic mice that develop early-onset and progressive cerebral microvascular amyloid deposition 27 . In the rTg-DI rats, we similarly expressed the human APP transgene harboring the Swedish familial AD mutations and the -secretase cleavage site and the chimeric Dutch E693Q/Iowa D694N familial CAA mutations in neurons in the brain. Indeed, low level neuronal expression of the human APP transgene was observed in the rTg-DI rats ( Figure 1 ).
This phenotype is important because it signifies that our new CAA model does not require abnormal, vast over-expression of human APP and production of human A, that is commonly found in other transgenic rodent models, which can introduce potential confounds on neuronal function. This underscores that the robust cerebral accumulation of A and specific development of microvascular CAA is a consequence of the chimeric familial Dutch/Iowa mutations in the A peptide that is produced in the brains of these rats. Interestingly, the early-onset development of microvascular CAA and associated neuroinflammation coincides with early-onset and sustained cognitive deficits in rTg-DI rats and offers the promise of a unique model for the future elucidation as to how CAA can promote VCID.
The type and form of amyloid that accumulates in the cerebral microvasculature of rTg-DI rats is remarkably similar to what is found in human CAA. For example, in contrast to parenchymal amyloid plaques that largely accumulate fibrillar A42 in both humans and rodent models, the fibrillar cerebral vascular amyloid deposits in rTg-DI rats are composed primarily of the shorter A40 species 53, 54 . In addition to the difference in the length of the A peptide that forms the amyloid fibrils in either parenchymal plaques or cerebral vascular deposits other micro-structural differences have been found. Recently, we found that fibrils produced from seeds of cerebral vascular fibrillar amyloid deposits exhibit increased intensity in FTIR spectra that is characteristic of anti-parallel structure of the  strands forming the backbone of the A fibrils 33 . This structure is distinct from the parallel registry observed in parenchymal plaque amyloid fibrils 55, 56 . The -sheet,
anti-parallel fibril character is also observed in the cerebral microvascular amyloid deposits of the rTg-DI rats (Figure 3 The data show that cerebral capillaries in rTg-DI rats exhibit structural abnormalities, increased tortuosity and, in the thalamic region, increased vascularization. Twelve months old brain sections from rTg-DI rats were stained for hemosiderin to identify microhemorrhages (blue) in the cortex (A), hippocampus (B) and the thalamus (C-F).
Scale bars = 50 µm. The percent area fraction of hemosiderin staining was quantitated in the cortex, hippocampus and thalamus of six months old (gray) and twelve months old (red) rTg-DI rats (G). Data represent the mean ± S.D. of 6-7 rTg-DI rats per group.
Progressive and consistent accumulation of microbleeds was observed, particularly in the thalamus, of rTg-DI rats. Twelve months old brain sections from rTg-DI rats were stained for hemosiderin to identify microhemorrhages (blue) and counterstained with pararosanline (pink) in the thalamus (A). Scale bar = 50 µm. Adjacent tissue sections were stained for calcium (black) and counterstained with pararosanline (pink) in the thalmus (B) . Scale bar = 50 µm. Lower magnification revealed that the occluded, calcified microvessels were restricted to the thalamic region (C). Scale bar = 200 µm. The number of thalamic microvessel occlusions were counted in progressively aged rTg-DI rats (D). Data represent the mean ± S.D. of 5-6 rTg-DI rats per group. Numerous occluded capillary/microvessels were observed around microbleeds specifically in the thalamic region of rTg-DI rats. 
